SCHEMBL2215955

SCHEMBL2215955

O=C(O)c1cc2c3ccccc3n(Cc3ccccc3)c2c(Cc2ccccc2)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.49
KDM4E B2RXH2 4/20 0.47
HSD17B10 Q99714 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CCR2 P41597 2/20 0.46
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 1/20 0.45
P2RX4 Q99571 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
FOLH1 Q04609 1/20 0.43
EGLN1 Q9GZT9 1/20 0.42
MAPK1 P28482 1/20 0.42
POLB P06746 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2214735 0.90 CYP19A1 (0.47) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL28273846 0.90 CYP19A1 (0.47) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL28273845 0.90 CYP19A1 (0.47) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL28273840 0.89 CYP19A1 (0.46) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL2212262 0.88 PDE4A (0.48) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL2218201 0.86 AGTR1 (0.47) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL2215283 0.85 CYP19A1 (0.49) CYP19A1KDM4EHSD17B10CYP1A2CYP2C9
SCHEMBL29217042 0.84 KDM4E (0.53) KDM4EHSD17B10CCR2MEN1KMT2A
SCHEMBL29217015 0.84 CCR2 (0.48) KDM4EHSD17B10CYP1A2CYP2C9CYP2C19
SCHEMBL29217013 0.83 MEN1 (0.48) KDM4EHSD17B10L3MBTL1CCR2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1634881-B1 HARMINE DERIVATIVES, INTERMEDIATES USED IN THEIR PREPARATION, PREPARATION PROCESSES AND USE THEREOF XINJIANG HUASHIDAN PHARMACEUTICAL RES CO LTD (CN) 2011-07-27 EP claimed